Skip to content
OpenCapital
Get started

USA Compression Partners USAC Accrued capital expenditures

Other financials

Income statement

See full
Revenue$331.3M+35.1%
Gross profit$213.4M+30.4%
Operating income$91.4M+31.7%
Net income$38.3M+86.9%
EPS (diluted)$0.22+22.2%

Balance sheet

See full
Cash & equivalents$14.5M+726,000%
Total debt$3.0B+17.5%
Total assets$3.7B+37.6%

Cash flow

See full
Operating cash flow$86.1M+57.6%
CapEx$24.2M+32.0%
Free cash flow$61.9M+70.5%

Valuation

See full
Market cap$3.81B+24.0%

Profitability

See full
Gross margin66.3%-0.6pp
Operating margin30.3%-0.4pp
Net margin11.9%+1.9pp
FCF margin27.9%+6.6pp

Returns & leverage

See full
Current ratio1.5×+0.1×

Where this comes from

Reported directly by USA Compression Partners in its filing.

Tagged under the XBRL concept usac:AccruedCapitalExpenditures.

The official record: USA Compression Partners’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is USA Compression Partners's accrued capital expenditures?
USA Compression Partners (USAC) reported accrued capital expenditures of $5.1M in Q1 2026.
How has USA Compression Partners's accrued capital expenditures changed year-over-year?
USA Compression Partners's accrued capital expenditures decreased by 30.8% year-over-year, from $7.37M to $5.1M.
What is the long-term trend for USA Compression Partners's accrued capital expenditures?
Over 4 years (2021 to 2025), USA Compression Partners's accrued capital expenditures has grown at a 11.4% compound annual growth rate (CAGR), from $3.52M to $5.43M.